SCHEMBL2047002

SCHEMBL2047002

CC(=O)OCCO.[LiH]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27796 0.97
SCHEMBL3070371 0.97 ALDH1A1 (0.55)
Ethylene Glycol SCHEMBL7784600 0.94 ALDH1A1 (0.52)
SCHEMBL21580547 0.94
SCHEMBL11123022 0.94
SCHEMBL25232908 0.94
Water SCHEMBL58538 0.94
SCHEMBL15106933 0.94
SCHEMBL4951741 0.94 ALDH1A1 (0.56)
SCHEMBL28479570 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109957573-B Haynaldia villosa vacuolus processing enzyme gene VPE3-V and silencing vector and application thereof 南京农业大学 2022-08-16 CN disclosed
CN-108342392-A One chloroplaset gene location ToxABP1-V and its application 南京农业大学 2018-07-31 CN disclosed
CN-105513820-B A kind of preparation method of lithium manganese phosphate material of carbon coating and products thereof and application 浙江大学 2018-03-16 CN disclosed
CN-105513820-A Preparation method of carbon-coated LiMnPO4 material, and product and application of carbon-coated LiMnPO4 material UNIV ZHEJIANG 2016-04-20 CN disclosed
EP-2045251-B1 COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES CONSEJO SUPERIOR INVESTIGACION (ES) 2015-11-18 EP disclosed
US-8785430-B2 Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2014-07-22 US disclosed
US-20130237529-A1 COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS 2013-09-12 US disclosed
US-8252786-B2 Compound that can inhibit UBC13-UEV interactions, pharmaceutical compositions and therapeutic uses CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2012-08-28 US disclosed
US-20110160189-A1 COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) 2011-06-30 US disclosed
EP-2045251-A1 COMPOUND THAT CAN INHIBIT UBC13-UEV INTERACTIONS, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC USES Consejo Superior de Investigaciones Cientificas (ES) 2009-04-08 EP disclosed
US-20080038723-A1 Functional assessment of DNA mismatch repair gene variants BITTECH ONCOLOGIC CORP. 2008-02-14 US disclosed
EP-1386003-A4 FUNCTIONAL GENETIC TESTS OF DNA MISMATCH REPAIR BITTECH ONCOLOGIC CORP (US) 2004-08-04 EP disclosed
EP-1386003-A2 FUNCTIONAL GENETIC TESTS OF DNA MISMATCH REPAIR Bittech Oncologic Corp. (US) 2004-02-04 EP disclosed
US-20030138787-A1 Functional genetic tests of DNA mismatch repair BITTECH ONCOLOGIC CORP. 2003-07-24 US disclosed
US-6566066-B1 Nucleotide sequences coding polypeptide for use in the diagnosis, treatment and prevention of diabetes and pancreatic defects INCYTE GENOMICS, INC. 2003-05-20 US disclosed
WO-2002081624-A2 FUNCTIONAL GENETIC TESTS OF DNA MISMATCH REPAIR BITTECH ONCOLOGIC CORP. (US) 2002-10-17 WO disclosed